Open AccessAfamelanotide and Narrowband UV-B Phototherapy for the Treatment of Vitiligo
Author(s) -
Henry W. Lim,
Pearl E. Grimes,
Oma N. Agbai,
Iltefat Hamzavi,
Marsha Henderson,
Madelaine Haddican,
Rita V Linkner,
Mark Lebwohl
Publication year - 2014
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2014.1875
Subject(s) - vitiligo , medicine , combination therapy , dermatology , group b , ultraviolet therapy , psoriasis
Narrowband UV-B (NB-UV-B) phototherapy is used extensively to treat vitiligo. Afamelanotide, an analogue of α-melanocyte-stimulating hormone, is known to induce tanning of the skin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom